UGT1A6 GENOTYPE-RELATED PHARMACOKINETICS OF PROPRANOLOL IN HEALTHY VOLUNTEERS: PRELIMINARY DATA

被引：0
|
作者：
Tankanitlert, J. [1 ]
Yamanont, P. [2 ]
Jirasomprasert, T. [2 ]
Rodrat, S. [2 ]
Morales, Phumala N. [2 ]
机构：
[1] Phramongkutklao Coll Med, Bangkok, Thailand
[2] Mahidol Univ, Fac Sci, Bangkok 10400, Thailand
来源：
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY | 2009年 / 105卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：80 / 80
页数：1
相关论文
共 50 条
  • [41] SAFETY AND PHARMACOKINETICS OF CDP6038, AN ANTI-IL-6 MONOCLONAL ANTIBODY, ADMINISTERED BY SUBCUTANEOUS INJECTION AND INTRAVENOUS INFUSION TO HEALTHY MALE VOLUNTEERS: A PHASE 1 STUDY
    Hickling, M.
    Golor, G.
    Jullion, A.
    Shaw, S.
    Kretsos, K.
    RHEUMATOLOGY, 2012, 51 : 146 - 147
  • [42] Influence of CYP2D6, CYP3A4, CYP3A5 and ABCB1 Polymorphisms on Pharmacokinetics and Safety of Aripiprazole in Healthy Volunteers
    Belmonte, Carmen
    Ochoa, Dolores
    Roman, Manuel
    Saiz-Rodriguez, Miriam
    Wojnicz, Aneta
    Isabel Gomez-Sanchez, Clara
    Martin-Vilchez, Samuel
    Abad-Santos, Francisco
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2018, 122 (06) : 596 - 605
  • [43] A phase 1, dose-escalation and dose-expansion study evaluating the safety, tolerability, pharmacokinetics and preliminary efficacy of AHB-137 in Chinese healthy volunteers and subjects with chronic hepatitis B
    Wang, Wen
    Liang, Xieer
    Ren, Hong
    Yu, Xian
    Xu, Chongyuan
    Mai, Jiajia
    Hou, Jinlin
    Zhang, Hong
    Kuang, Fu
    Wang, Junting
    Lan, Tianwen
    Wen, Yilei
    Cao, Haixia
    Lu, Bingxia
    Wu, Xiaoli
    Lu, Tingting
    Qiu, Xiao
    Yang, Chen
    Wang, Lidan
    Zhao, Di
    Wang, Miao
    Yang, Cheng Yong
    Cheng, Guofeng
    Niu, Junqi
    Ding, Yanhua
    JOURNAL OF HEPATOLOGY, 2024, 80 : S99 - S99
  • [44] AKR1D1*36C>T (rs1872930) allelic variant is associated with variability of the CYP2C9 genotype predicted pharmacokinetics of ibuprofen enantiomers - a pilot study in healthy volunteers
    Nestorovska, Aleksandra Kapedanovska
    Jakjovski, Krume
    Naumovska, Zorica
    Sterjev, Zoran
    Geskovska, Nadica Matevska
    Mladenovska, Kristina
    Suturkova, Ljubica
    Dimovski, Aleksandar
    ACTA PHARMACEUTICA, 2019, 69 (03) : 399 - 412
  • [45] DA-1241 a novel GPR119 agonist: Data on safety, tolerability and pharmacokinetics (PK), from part 1 of a phase 1b multiple ascending dose (MAD) study in healthy volunteers (HV)
    Franey, B.
    Grimm, M.
    Lee, D.
    Jeong, J.
    Kim, M. -K.
    Hompesch, M.
    DIABETOLOGIA, 2021, 64 (SUPPL 1) : 241 - 242
  • [46] Effects of Genetic Polymorphism in CYP2D6, CYP2C19, and the Organic Cation Transporter OCT1 on Amitriptyline Pharmacokinetics in Healthy Volunteers and Depressive Disorder Patients
    Matthaei, Johannes
    Brockmoeller, Juergen
    Steimer, Werner
    Pischa, Konstanze
    Leucht, Stefan
    Kullmann, Maria
    Jensen, Ole
    Ouethy, Typhaine
    Tzvetkov, Mladen Vassilev
    Rafehi, Muhammad
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [47] DA-1241, a Novel GPR119 Agonist: Data on Safety, Tolerability, and Pharmacokinetics (PK) from Part 1 of a Phase lb Multiple Ascending Dose (MAD) Study in Healthy Volunteers (HV)
    Kim, Mi-Kyung
    Lee, Dae Young
    Jeong, Jiyoon
    Grimm, Michael
    Franey, Bridgette B.
    Hompesch, Marcus
    DIABETES, 2021, 70
  • [48] Effect of Ketoconazole on the Pharmacokinetics of the 11β-Hydroxysteroid Dehydrogenase Type 1 Inhibitor ABT-384 and Its Two Active Metabolites in Healthy Volunteers: Population Analysis of Data from a Drug-Drug Interaction Study
    An, Guohua
    Liu, Wei
    Katz, David A.
    Marek, Gerard
    Awni, Walid
    Dutta, Sandeep
    DRUG METABOLISM AND DISPOSITION, 2013, 41 (05) : 1035 - 1045
  • [49] Safety, Tolerability, Pharmacokinetics (PK) and Antiviral Activity of EDP-494, a Potent Pan-Genotypic Cyclophilin (Cyp) Inhibitor for Chronic Hepatitis C Infection (CHC), in Healthy Subjects (HS) and in CHC Genotype 1 and 3 Patients: Preliminary Result
    Gane, Edward J.
    Jiang, Lijuan
    Schwabe, Christian
    Morelli, Lisa
    Lin, Kai
    Or, Yat Sun
    Adda, Nathalie
    HEPATOLOGY, 2016, 64 : 726A - 727A
  • [50] Belatacept, a Co-Stimulatory Immunomodulator, Has No Impact On the Pharmacokinetics of Several Probe Substrates of Cytochrome P450 1A2, 3A4, 2C9, 2C19, and 2D6 in Healthy Volunteers
    Tao, X.
    Zhu, L.
    Stonier, M.
    Lutz, J.
    Zhang, S.
    Ganguly, B.
    Tzogas, Z.
    Lubin, S.
    Williams, D.
    Masson, E.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 617 - 618
12345